GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (NAS:ALVO) » Definitions » Revenue

Alvotech (Alvotech) Revenue : $91.43 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech Revenue?

Alvotech's revenue for the three months ended in Dec. 2023 was $53.39 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $91.43 Mil. Alvotech's Revenue per Share for the three months ended in Dec. 2023 was $0.20. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.37.

Warning Sign:

Alvotech revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Alvotech was -4.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 5 years, Alvotech's highest 3-Year average Revenue per Share Growth Rate was 47.50% per year. The lowest was 13.80% per year. And the median was 30.65% per year.


Alvotech Revenue Historical Data

The historical data trend for Alvotech's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Revenue Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
31.92 66.62 36.77 83.03 91.43

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.86 15.86 4.39 17.79 53.39

Competitive Comparison of Alvotech's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Alvotech's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alvotech's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alvotech's Revenue distribution charts can be found below:

* The bar in red indicates where Alvotech's Revenue falls into.



Alvotech Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $91.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alvotech  (NAS:ALVO) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Alvotech Revenue Related Terms

Thank you for viewing the detailed overview of Alvotech's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Alvotech (Alvotech) Business Description

Traded in Other Exchanges
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.